[Primary generation in vitro of T killer lymphocytes specific against viral tumors, in the presence of interleukine 2].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000956:Antigens, Viral / Q000276:immunology*; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008222:Lymphokines / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D013950:Thymus Gland / Q000276:immunology
D000956:Antigens, Viral; C030663:FMR antigen; D007376:Interleukin-2; D008222:Lymphokines
Obtention grâce à l'interleukine 2 de lymphocytes T tueurs spécifiques de tumeurs virales en réaction primaire in vitro.